Across TCGA patient cohorts, NDUFA12 mutation is significantly associated with the RNA expression of many other genes, with 62 significant associations in total. LUAD shows the largest number of these associations.

The most reproducible NDUFA12-associated genes across cancer lineages are RPL9P13, MATR3P1, and RPL30P9. Each is linked with NDUFA12 in more than 1 cancer types. Because this analysis shows association rather than direction, both NDUFA12-to-partner and partner-to-NDUFA12 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (NDUFA12→partner) and Y-score (partner→NDUFA12) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
UCEC	RPL9P13 →	+0.172	+5.621	.005	.004	3	2
BLCA	MATR3P1 →	+0.198	+5.899	<.001	.002	3	2
SKCM	RPL30P9 →	+0.114	+7.816	<.001	.008	3	1
BLCA	SERPINA13P →	+0.168	+5.177	<.001	.007	3	1
BLCA	RNU6-1260P →	+0.567	+6.147	<.001	.002	3	1
BLCA	LINC02740 →	+0.069	+5.106	.006	.008	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 62 associations by consensus.

Exploration

NDUFA12 survival (RNA) · tumor vs normal (RNA) · all NDUFA12 data types